147 related articles for article (PubMed ID: 32127638)
1. Comprehensive genomic characterization of gene therapy-induced T-cell acute lymphoblastic leukemia.
Horak P; Uhrig S; Witzel M; Gil-Farina I; Hutter B; Rath T; Gieldon L; Balasubramanian GP; Pastor X; Heilig CE; Richter D; Schröck E; Ball CR; Brors B; Braun CJ; Albert MH; Scholl C; von Kalle C; Schmidt M; Fröhling S; Klein C; Glimm H
Leukemia; 2020 Oct; 34(10):2785-2789. PubMed ID: 32127638
[No Abstract] [Full Text] [Related]
2. Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicity.
Braun CJ; Boztug K; Paruzynski A; Witzel M; Schwarzer A; Rothe M; Modlich U; Beier R; Göhring G; Steinemann D; Fronza R; Ball CR; Haemmerle R; Naundorf S; Kühlcke K; Rose M; Fraser C; Mathias L; Ferrari R; Abboud MR; Al-Herz W; Kondratenko I; Maródi L; Glimm H; Schlegelberger B; Schambach A; Albert MH; Schmidt M; von Kalle C; Klein C
Sci Transl Med; 2014 Mar; 6(227):227ra33. PubMed ID: 24622513
[TBL] [Abstract][Full Text] [Related]
3. B-cell reconstitution after lentiviral vector-mediated gene therapy in patients with Wiskott-Aldrich syndrome.
Castiello MC; Scaramuzza S; Pala F; Ferrua F; Uva P; Brigida I; Sereni L; van der Burg M; Ottaviano G; Albert MH; Grazia Roncarolo M; Naldini L; Aiuti A; Villa A; Bosticardo M
J Allergy Clin Immunol; 2015 Sep; 136(3):692-702.e2. PubMed ID: 25792466
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy and safety of gene therapy for Wiskott-Aldrich syndrome].
Galy A; Corre G; Cavazzana M; Hacein-Bey-Abina S
Med Sci (Paris); 2015 Dec; 31(12):1066-9. PubMed ID: 26672655
[No Abstract] [Full Text] [Related]
5. Evidence for long-term efficacy and safety of gene therapy for Wiskott-Aldrich syndrome in preclinical models.
Marangoni F; Bosticardo M; Charrier S; Draghici E; Locci M; Scaramuzza S; Panaroni C; Ponzoni M; Sanvito F; Doglioni C; Liabeuf M; Gjata B; Montus M; Siminovitch K; Aiuti A; Naldini L; Dupré L; Roncarolo MG; Galy A; Villa A
Mol Ther; 2009 Jun; 17(6):1073-82. PubMed ID: 19259069
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy for Wiskott-Aldrich syndrome: here to stay.
Candotti F
Lancet Haematol; 2019 May; 6(5):e230-e231. PubMed ID: 30981782
[No Abstract] [Full Text] [Related]
7. [Wiskott-Aldrich syndrome: a new advance in gene therapy].
Nau JY
Rev Med Suisse; 2015 Apr; 11(472):996-7. PubMed ID: 26062229
[No Abstract] [Full Text] [Related]
8. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
[TBL] [Abstract][Full Text] [Related]
9. Current and emerging treatment options for Wiskott-Aldrich syndrome.
Worth AJ; Thrasher AJ
Expert Rev Clin Immunol; 2015; 11(9):1015-32. PubMed ID: 26159751
[TBL] [Abstract][Full Text] [Related]
10. The genomic landscape of teenage and young adult T-cell acute lymphoblastic leukemia.
Mansur MB; Furness CL; Nakjang S; Enshaei A; Alpar D; Colman SM; Minto L; Irving J; Poole BV; Noronha EP; Savola S; Iqbal S; Gribben J; Pombo-de-Oliveira MS; Ford TM; Greaves MF; van Delft FW
Cancer Med; 2021 Jul; 10(14):4864-4873. PubMed ID: 34080325
[TBL] [Abstract][Full Text] [Related]
11. Stem-cell gene therapy for the Wiskott-Aldrich syndrome.
Boztug K; Schmidt M; Schwarzer A; Banerjee PP; Díez IA; Dewey RA; Böhm M; Nowrouzi A; Ball CR; Glimm H; Naundorf S; Kühlcke K; Blasczyk R; Kondratenko I; Maródi L; Orange JS; von Kalle C; Klein C
N Engl J Med; 2010 Nov; 363(20):1918-27. PubMed ID: 21067383
[TBL] [Abstract][Full Text] [Related]
12. Clinical application of whole transcriptome sequencing for the classification of patients with acute lymphoblastic leukemia.
Walter W; Shahswar R; Stengel A; Meggendorfer M; Kern W; Haferlach T; Haferlach C
BMC Cancer; 2021 Aug; 21(1):886. PubMed ID: 34340673
[TBL] [Abstract][Full Text] [Related]
13. T-lymphoblastic lymphoma after previous thymoma: how NGS helps establishing the diagnosis and procures new insights.
Le Clef Q; Ortega-Sanchez G; Dirnhofer S; Tzankov A
Leuk Lymphoma; 2019 May; 60(5):1320-1323. PubMed ID: 30301393
[No Abstract] [Full Text] [Related]
14. Acute lymphoblastic leukemia as a second malignant neoplasm in a child with medulloblastoma.
Cağlar K; Unal S; Cetinkaya A; Gümrük F; Yetgin S
Pediatr Hematol Oncol; 2003; 20(7):535-7. PubMed ID: 12959858
[TBL] [Abstract][Full Text] [Related]
15. Therapy-related acute lymphoblastic leukemia is a distinct entity with adverse genetic features and clinical outcomes.
Saygin C; Kishtagari A; Cassaday RD; Reizine N; Yurkiewicz I; Liedtke M; Stock W; Larson RA; Levine RL; Tallman MS; Park JH; Kerr C; Przychodzen B; Sekeres MA; Kalaycio ME; Carraway HE; Hamilton BK; Sobecks R; Gerds A; Mukherjee S; Nazha A; Maciejewski JP; Advani AS
Blood Adv; 2019 Dec; 3(24):4228-4237. PubMed ID: 31869410
[TBL] [Abstract][Full Text] [Related]
16. Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome.
Hacein-Bey Abina S; Gaspar HB; Blondeau J; Caccavelli L; Charrier S; Buckland K; Picard C; Six E; Himoudi N; Gilmour K; McNicol AM; Hara H; Xu-Bayford J; Rivat C; Touzot F; Mavilio F; Lim A; Treluyer JM; Héritier S; Lefrère F; Magalon J; Pengue-Koyi I; Honnet G; Blanche S; Sherman EA; Male F; Berry C; Malani N; Bushman FD; Fischer A; Thrasher AJ; Galy A; Cavazzana M
JAMA; 2015 Apr; 313(15):1550-63. PubMed ID: 25898053
[TBL] [Abstract][Full Text] [Related]
17. Applications of Flow Cytometric Immunophenotyping in the Diagnosis and Posttreatment Monitoring of B and T Lymphoblastic Leukemia/Lymphoma.
DiGiuseppe JA; Wood BL
Cytometry B Clin Cytom; 2019 Jul; 96(4):256-265. PubMed ID: 31231940
[TBL] [Abstract][Full Text] [Related]
18. Secondary T-lymphoblastic leukemia in a patient with hairy cell leukemia following cladribine therapy: report of an extremely rare case and review of the literature.
Setoodeh R; Zhang L
Leuk Lymphoma; 2012 Apr; 53(4):736-8. PubMed ID: 21980957
[No Abstract] [Full Text] [Related]
19. An early thymic precursor phenotype predicts outcome exclusively in HOXA-overexpressing adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.
Bond J; Marchand T; Touzart A; Cieslak A; Trinquand A; Sutton L; Radford-Weiss I; Lhermitte L; Spicuglia S; Dombret H; Macintyre E; Ifrah N; Hamel JF; Asnafi V
Haematologica; 2016 Jun; 101(6):732-40. PubMed ID: 26944475
[TBL] [Abstract][Full Text] [Related]
20. Linking genomic lesions with minimal residual disease improves prognostic stratification in children with T-cell acute lymphoblastic leukaemia.
La Starza R; Lettieri A; Pierini V; Nofrini V; Gorello P; Songia S; Crescenzi B; Te Kronnie G; Giordan M; Leszl A; Valsecchi MG; Aversa F; Basso G; Biondi A; Conter V; Cazzaniga G; Mecucci C
Leuk Res; 2013 Aug; 37(8):928-35. PubMed ID: 23735857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
